1921
Volume 26, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

Menichlopholan, a biphenyl compound, in a single dose of 2 mg/kg body weight, gave a 73%–90% cure rate in the treatment of pulmonary infections due to at two centers in Nigeria. Ninety-five patients were followed up for 4 months, and 58 for 1 year. Side effects of the drug included sweating and body pains, but there was no significant biochemical or hematological evidence of damage to the internal organs. The advantages of single dose therapy are likely to make menichlopholan the treatment of choice for paragonimiasis in Africa, and probably elsewhere.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1977.26.688
1977-07-01
2017-11-23
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1977.26.688
Loading
  • Accepted : 18 Nov 1976

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error